SCHEMBL3852747

SCHEMBL3852747

Cc1cnc(NC(=O)c2ccc(-c3cnc4ccc(-c5cnn(C(c6ccccc6)(c6ccccc6)c6ccccc6)c5)cn34)cc2F)s1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.39
STIM1 Q13586 2/20 0.38
ORAI1 Q96D31 2/20 0.38
MET P08581 1/20 0.38
FLT3 P36888 2/20 0.36
CLK1 P49759 4/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
KDM4E B2RXH2 1/20 0.36
HPGD P15428 1/20 0.36
HSD17B10 Q99714 1/20 0.36
GSK3B P49841 2/20 0.36
DYRK1A Q13627 2/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
PKM P14618 1/20 0.36
GRM5 P41594 1/20 0.35
FGFR3 P22607 1/20 0.35
KDR P35968 1/20 0.35
MITF O75030 1/20 0.35
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3848697 0.88 ALDH1A1 (0.45) ALDH1A1METKDM4EHPGDHSD17B10
SCHEMBL3852108 0.87 CYP1A2 (0.39) ALDH1A1METCLK1SMN1; SMN2KDM4E
SCHEMBL3854810 0.86 MET (0.36) ALDH1A1METFLT3CLK1SMN1; SMN2
SCHEMBL3846730 0.85 IDO1 (0.40) METCLK1FGFR3KDR
SCHEMBL3845914 0.85 MAPK1 (0.42) ALDH1A1METCLK1SMN1; SMN2KDM4E
SCHEMBL3845025 0.85 SORT1 (0.41) ALDH1A1METCLK1SMN1; SMN2HPGD
SCHEMBL3851356 0.85 KDR (0.46) ALDH1A1SMN1; SMN2KDM4ENPC1RAB9A
SCHEMBL3871634 0.84 ALDH1A1 (0.42) ALDH1A1METHPGDLMNA
SCHEMBL3851316 0.84 MET (0.41) METFLT3CLK1FGFR3KDR
SCHEMBL3852095 0.84 ALDH1A1 (0.46) ALDH1A1METCLK1SMN1; SMN2FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed